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Abstract Calreticulin (CRT) is an abundant molecular chaper-
one of the endoplasmic reticulum. Its central, proline-rich
P-domain, comprising residues 189^288, contains three copies
of each of two repeat sequences (types 1 and 2), which are
arranged in a characteristic ‘111222’ pattern. Here we show that
the three-dimensional structure of CRT(189^288) contains a
single hairpin fold formed by the entire polypeptide chain. The
loop at the bottom of the hairpin consists of residues 227^247,
and is closed by an anti-parallel L-sheet of residues 224^226 and
248^250. Two additional L-sheets contain residues 207^209 and
262^264, and 190^192 and 276^278. The 17-residue spacing of
the L-strands in the N-terminal part of the hairpin and the
14-residue spacing in the C-terminal part reflect the length of
the type 1 and type 2 sequence repeats. As a consequence
of this topology the peptide segments separating the L-strands
in the N-terminal part of the hairpin are likely to form bulges
to accommodate the extra residues. These results are based
on nearly complete sequence-specific NMR assignments
for CRT(189^288), which were obtained using standard
NMR techniques with the 13C/15N-labeled protein, and collec-
tion of nuclear Overhauser enhancement upper distance
constraints. ß 2001 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The endoplasmic reticulum (ER) of eukaryotic cells con-
tains a complex machinery for assisted folding of newly syn-
thesized proteins as well as a quality control system to ensure
their structural integrity [1,2]. The calcium-binding molecular
chaperone calreticulin (CRT) and its close homolog calnexin
(CNX) play a pivotal role in these processes. Both proteins
are lectins that associate transiently with nascent and newly
synthesized glycoproteins in living cells [3^5], by interacting
with partially trimmed, monoglucosylated N-linked oligosac-
charide moieties [6^8]. They co-operate with independently
acting enzymes that regulate the cycle of substrate binding
to and release from the chaperones [9,10]. Furthermore,
they associate with ERp57, a thiol oxidoreductase that is in-
volved in formation of disul¢de bonds [11].
CRT (400 amino acids, 46 kDa) is a highly conserved solu-
ble protein (for a review on CRT see [12]). The amino acid
sequence shows three regions, the N-, P- and C-domains, with
somewhat arbitrarily de¢ned boundaries. The C-domain (res-
idues 286^400) contains the KDEL sequence for ER retrieval.
Being highly negatively charged it binds approximately 25 mol
Ca2/mol protein, making CRT one of the major calcium-
binding proteins of the ER. Much interest has been focused
on the proline-rich domain (P-domain) (residues 171^285),
which has a unique, proline-rich sequence with two sequence
repeats of 17 (type 1) and 14 residues (type 2), respectively.
CRT comprises three copies of each repeat type in a ‘111222’
arrangement (Fig. 4), while CNX has four copies in a
‘11112222’ arrangement. The P-domain has been shown to
contain a high a⁄nity Ca2-binding site [13], and since it is
a central part of all truncated constructs that retain binding
for glycoproteins [14,15] it has been implicated in substrate
binding.
To date, the three-dimensional (3D) structure of neither
CRT nor CNX is known, although the crystallization of a
CNX ecto-domain fragment has been published [16]. Analyt-
ical ultracentrifugation and gel-¢ltration indicate that CRT is
a highly asymmetric molecule ([17]; M. Bouvier, personal
communication). Secondary structure prediction programs
predict that the P-domain is devoid of regular secondary
structure elements, which may at least in part be rationalized
by the high content of prolyl residues. Here we describe the
3D structure topology of rat CRT(189^288) determined by
nuclear magnetic resonance (NMR) spectroscopy in solution
[18].
2. Materials and methods
2.1. Protein expression and puri¢cation
The ‘pGEX-CRTwt’ vector [15] containing the full-length rat CRT
cDNA (GenBank accession number X79327) was used as the template
in a PCR reaction to generate a fragment encoding the amino acid
residues 189^288. The PCR product was cloned into a pRSET A-
derived Escherichia coli expression vector [19] (kindly provided by
Dr. A. Fersht). This vector encodes a N-terminal 17-amino acid tail
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that includes a hexa-histidine segment and a thrombin cleavage site.
After thrombin cleavage, a GS dipeptide segment remains at the N-
terminus of the CRT(189^288) construct. The correct sequence of the
construct was veri¢ed by DNA sequencing.
To produce 13C/15N-labeled CRT(189^288), a preculture of 65 ml
LB medium containing ampicillin (100 Wg/ml) and chloramphenicol
(34 Wg/ml) was inoculated with 1 ml overnight culture of E. coli
BL21(DE3)pLysS cells freshly transformed with expression plasmid.
The culture was grown at 37‡C until reaching an OD600 of 0.8, har-
vested by centrifugation and resuspended in 50 ml prewarmed M9
minimal medium containing 20 WM CaCl2, 1 mM MgSO4 and anti-
biotics as described above. The medium was supplemented with 2 g/l
13C-glucose and 1 g/l 15NH4Cl for isotope labeling. The resuspended
cells were inoculated into 450 ml M9 medium supplemented as de-
scribed above and then grown to OD600 = 0.6. Induction of expression
was initiated by adding 1 mM isopropyl L-D-galactopyranoside
(IPTG). The cells were harvested after 8 h and resuspended in 30
ml of bu¡er A (6 M guanidinium^HCl, 50 mM Tris^HCl pH 8.0,
10 mM reduced glutathione) containing 100 mM NaCl.
Following sonication, the clear supernatant obtained by centrifuga-
tion at 20 000Ug for 30 min was applied to a Ni2-charged nitrilotri-
acetic acid (NTA) metal^chelate a⁄nity column (15 ml), which was
washed thoroughly with bu¡er A containing 1 M NaCl. Applying a
linear bu¡er gradient, the guanidinium^HCl wash bu¡er was gradu-
ally replaced by an aqueous bu¡er B (500 mM NaCl, 50 mM Tris^
HCl pH 8.0, 2 mM CaCl2). After washing the column with bu¡er B
containing 25 mM imidazole, the fusion protein was eluted from the
Ni2^NTA column with bu¡er B containing 500 mM imidazole.
Removal of the N-terminal fusion tail was achieved by digesting
with 2.5 units of thrombin per mg of fusion protein for 24 h at room
temperature. The digest was diluted 20-fold with bu¡er C (25 mM
NaCl, 25 mM Tris^HCl pH 8.0) and loaded onto a MonoQ 10/10
anion-exchange column (Pharmacia) before elution with a linear gra-
dient against bu¡er C containing 400 mM NaCl. Finally, the protein
was gel-¢ltrated into a 10-mM CaCl2 solution and concentrated using
Centricon spin columns (Amicon). Pure, uniformly 13C/15N-labeled
CRT(189^288) was obtained in yields of 7 mg per liter of M9 minimal
medium. For preparation of the NMR sample in D2O solution, the
H2O solution was replaced by successive concentration and dilution
steps. The correct molecular mass of the protein was veri¢ed by ma-
trix-assisted laser desorption and ionization time of £ight (MALDI-
TOF) mass spectrometry. Since no activity assay exists, the structural
integrity of the refolded CRT(189^288) was probed by circular dichro-
ism (CD) spectroscopy (data not shown), which revealed a co-oper-
ative thermal denaturation transition of the protein with a mid-point
temperature of approximately 35‡C.
2.2. NMR spectroscopy and structure determination
All NMR spectra were acquired with uniformly 13C/15N-labeled
CRT(189^288) at a protein concentration of 3 mM in 95% H2O/5%
D2O and at 1.5 mM protein concentration in 100% D2O, pH = 6.3,
T = 20‡C, 10 mM CaCl2. The NMR measurements were performed on
Bruker DRX600, DRX750 and DRX800 spectrometers equipped with
four radio-frequency channels and triple resonance probeheads with
shielded z-gradient coils. For the resonance assignments and collec-
tion of conformational constraints the following experiments were
recorded: 3D HNCA [20], 3D CBCA(CO)NH [20], 3D ct-HCCH-
TOCSY with 14 ms mixing time [21], 3D 1H-TOCSY-relayed ct-
[13C,1H]HMQC [22], 3D combined 15N/13C-resolved [1H,1H]-nuclear
Overhauser enhancement spectrometry (NOESY) [23,24] in H2O,
13CR-resolved [1H,1H]-NOESY [23] in H2O, and 13C-resolved
[1H,1H]-NOESY [23] in D2O. NOESY spectra were recorded with
mixing times dm = 60 ms. The 1H, 15N and 13C chemical shifts are
Fig. 1. Diagonal plot of the NOE constraints identi¢ed in
CRT(189^288). The sequence numbering is shown on both axes. A
square indicates the presence of a NOE between a pair of residues.
The darkness of the squares increases with increasing number of
NOE constraints between the two residues, with black squares rep-
resenting ¢ve or more NOEs. No distinction is made between NOEs
involving backbone or side chain hydrogens.
Fig. 2. Topology of the 3D structure of the CRT P-domain. The se-
quence positions of the ¢rst and last residues in the six L-strands
are indicated. Vertical dotted lines represent the interstrand dKK(i,j)
NOE connectivities across the L-sheets (see Fig. 5).
Fig. 3. 2D [15N, 1H]-COSY spectrum of CRT(189^288) with back-
bone 15N^1H resonance assignments. The insert in the lower right
contains the indole 15NO^1H cross peaks of the six tryptophanyl res-
idues. The sequence numbering is that of rat CRT, GenBank acces-
sion number CAA55890.
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calibrated relative to 2,2-dimethyl-2-silapentane-5-sulfonate, sodium
salt (DSS). The spectra were processed with the program PROSA
[25] and analyzed with the program XEASY [26]. Initial structure
calculations were performed using a new version of the program
DYANA [27] integrated with a new algorithm for automated NOE
cross peak assignment, CANDID (T. Herrmann, P. Gu«ntert and K.
Wu«thrich, unpublished).
3. Results and discussion
The diagonal plot of the NOE constraints in Fig. 1 contains
a ‘double diagonal’ pattern, where the diagonal going from
bottom left to top right of the plot shows sequential and
medium-range upper distance constraints, and the second, ap-
proximately perpendicular diagonal shows long-range con-
straints [18]. This pattern of NOE constraints shows that
the P-domain forms an extended hairpin fold, where the
two sides of the hairpin run anti-parallel to each other, the
N- and C-termini are in close proximity, and the hairpin does
not fold back on itself (Fig. 2). In the following we describe
the NMR experiments that resulted in the characterization of
the global fold of CRT(189^288) and some further details of
the molecular architecture, as surveyed in Fig. 4.
3.1. NMR assignment of CRT(189^288)
The NMR data in Fig. 1 and the schematic representation
of the polypeptide fold in Fig. 2 are based on nearly complete
sequence-speci¢c resonance assignments of CRT(189^288).
These are surveyed in the 2D [15N, 1H]-COSY spectrum of
CRT(189^288) in Fig. 3, and in a plot of the key data versus
the amino acid sequence in Fig. 4. The sequential assignment
was based on standard triple resonance spectra and on se-
quential NOEs [20,28,29]. Nearly complete sequential assign-
ments were eventually obtained from a HNCA spectrum [20]
in combination with sequential NOE connectivities [28,29]
(Fig. 4). Out of 84 backbone amide resonances expected in
the 2D [15N, 1H]-COSY spectrum we identi¢ed 81 (Fig. 3).
The three missing resonances are those of Arg205, Gly256 and
Gly270, but we were able to observe Gly256 in the 3D com-
bined 15N/13C-resolved [1H, 1H]-NOESY spectrum recorded
in H2O. Out of 16 Xxx^Pro dipeptide segments, 14 were iden-
ti¢ed based on sequential dKN and dLN NOE connectivities [18].
The chemical shift lists have been deposited in the BioMa-
gResBank (accession number 4878).
In the 2D [15N, 1H]-COSY spectrum (Fig. 3) some addi-
tional, so far unassigned weak peaks are observed, mostly
located next to strong signals from £exible residues near the
C-terminus. These may re£ect the presence of minor popula-
tions of one or several conformational isoforms of CRT(189^
288), which might typically arise from cis/trans isomerization
of Xxx^Pro peptide bonds [18].
Fig. 4. Survey of sequential and medium-range NOE connectivities, sequential connectivities observed in a HNCA spectrum, and deviation of
observed 13CK chemical shifts from the random coil values for CRT(189^288). The positions of the six L-strands (L1^L6) and a helix-like region
(H) as deduced from the NOESY data are indicated above the sequence. The arrows above the sequence indicate the positions of the type 1
and type 2 repeats in the CRT sequence. For the sequential NOE connectivities dNN , dKN and dLN the thickness of the line is proportional to
the NOE intensity. Open bars in the dKN and dLN rows indicate sequential dKN and dLN NOEs for Xxx^Pro dipeptide segments. Medium-range
NOEs are represented by lines connecting the two interacting residues. In the vN (13CK) row the di¡erence between corresponding observed and
random coil chemical shifts is indicated by ¢lled and open circles for residues with vN (13CK)s 1.0 ppm and vN (13CK)631.0 ppm, respec-
tively. All residues preceding a prolyl residue showed vN (13CK)631.0 ppm, which is not indicated in the ¢gure [34]. The N-terminal seryl resi-
due is not part of the native CRT sequence.
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3.2. Regular secondary structures and topology of
CRT(189^288)
The data in Figs. 1 and 4 provide only little information
on regular secondary structures in CRT(189^288), which may
to a large part be due to the high Pro content. A short helix-
like structure near E239 was identi¢ed based on medium-
range NOEs (see Fig. 4). As judged from the presence of
dKN (i,i+2) connectivities, this segment shows characteristics
of a 310 helix [30]. In principle, the global hairpin arrangement
of the polypeptide chain could accommodate extensive forma-
tion of anti-parallel L-sheet structure. However, long-range
HK-HK NOEs indicative of anti-parallel L-sheets [18] were
found in the 3D 13C-resolved [1H, 1H]-NOESY spectra only
between the residue pairs (190, 278), (192, 276), (207, 264),
(209, 262), (224, 250) and (226, 248) (Fig. 5), which de¢ne the
short L-sheets depicted in Fig. 2. The presence of these
L-sheets was supported by further NOE constraints, and is
compatible with the 13CK chemical shift data (Fig. 4) [31,32].
As shown in Fig. 4, the position of the L-strands L1, L2 and
L3 is the same within each type 1 repeat sequence, and the
position of the L-strands L4, L5 and L6 is the same within
each type 2 repeat sequence. In the 3D structure topology of
CRT(189^288) (Fig. 2), this leads to equidistant spacing of the
L-strands within each side of the hairpin, but di¡erent spac-
ings on the two sides. Thus, the distances between L1 and L2,
and between L2 and L3 is 17 residues, which re£ects the length
of the type 1 repeat sequence (see Fig. 4). Likewise, the length
of the type 2 repeat sequence is re£ected in the 14-residue
distances between L4 and L5, and between L5 and L6. There-
fore, the repetitive nature of the P-domain sequence also
seems to be maintained on the 3D structure level, which sug-
gests the formation of ‘bulges’ to accommodate the extra three
residues of the peptide segments between L1 and L2, and
between L2 and L3 (Fig. 2). By extension of this topology,
the CNX P-domain, which has an additional set of sequence
repeats, would also contain an additional L-sheet when com-
pared with CRT.
With the N- and C-termini located in close proximity to
each other, the P-domain could constitute a ¢nger-like exten-
sion from the CRT core structure. This could explain the
unusual hydrodynamic properties of the protein. Whereas it
is possible that this structure could provide a binding site for
glycans, it seems more likely to be a site for protein^protein
interactions, for instance involving the co-chaperone ERp57
with which both CNX and CRT form a complex [11]. Alter-
natively, the P-domain could be the recently described site of
direct interaction with misfolded proteins [33].
In conclusion, the CRT(189^288) fragment shows a unique
global fold, which seems to be intimately related with long-
recognized features of the primary structure. The ongoing
re¢nement of the solution NMR structure (L. Ellgaard, R.
Riek, T. Herrmann, P. Gu«ntert, D. Braun, A. Helenius and
K. Wu«thrich, to be published) should reveal the intramolecu-
lar contacts that stabilize this polypeptide fold, in addition to
the three short L-sheets shown in Fig. 2.
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Fig. 5. Identi¢cation of three anti-parallel L-sheets in CRT(189^
288). Spectral regions from 3D 13C-resolved [1H, 1H]-NOESY spec-
tra recorded either in H2O solution (residues Lys190, Lys192,
Glu276, Asp278) or in D2O solution (residues Lys207, Asp209,
His224, Pro226, Val248, Gln250, Gln262, Asp264) are shown.
Squares connect the cross peaks and the diagonal positions for the
dKK(i,j) connectivities between the residue pairs shown.
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